Product Description
Ubidecarenone, also known as coenzyme Q10 or CoQ10, is a biologically active compound similar in chemical structure to vitamins K and E. Part of a family of quinone compounds known as coenzyme Q, CoQ10 is characterized by a quinone ring attached to a repeating series of side chain isoprene units.
Mechanisms of Action: NLRP3 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Australia | Austria | Bangladesh | Canada | Chile | China | Dominican Republic | Ecuador | Hong Kong | Hungary | India | Ireland | Italy | Korea | Latvia | Lebanon | Malaysia | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Taiwan | Turkey | United Arab Emirates | United Kingdom | Uruguay | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|